Alcon's Clareon Panoptix Pro IOL enhances cataract surgery with advanced light utilization and low visual disturbance.

Dry eye is very common, especially post corneal refractive surgery, and should be treated preoperatively with attention paid ...

According to a 2025 report on Cataract Surgery Devices Market by Mordor Intelligence, the global market is expected to grow from USD 8.90 billion in 2025 to USD 10.

Alcon Inc. (NYSE: ALC) is one of the 11 Best 52-Week Low Stocks to Buy Right Now. On June 20, Alcon Inc. (NYSE:ALC) announced ...

SINGAPORE – Eye-care device firm Alcon Manufacturing and Logistics announced the opening of its expanded manufacturing and logistics facility on June 27. The facility, located in Tuas, will ...

Meanwhile, BofA Securities adjusted its price target to CHF89 after Alcon’s challenging first quarter, while maintaining a Buy rating, focusing on the company’s structural growth potential.

This is a developing news story. Please check back soon for updates. Alcon will acquire LumiThera, including its ...

Alcon describes itself as the global leader in eye care with products that reach more than 260 million people in over 140 countries annually. The company’s global reach is reflected in its ...

Eye care-device giant Alcon officially opened its expanded state-of-the art manufacturing and logistics facility in Tuas Biomedical Park on Friday (June 27) morning. This brings Alcon's ...

Michelle Dixon, VP of Manufacturing & Technical Operations Management for Vision Care, Alcon, said the expansion will also create high-value jobs across production, quality control, and distribution.

TORONTO - Alcon (SIX/NYSE: ALC), a prominent player in the Healthcare Equipment & Supplies industry with a market capitalization of $42 billion, has received approval for its Clareon PanOptix Pro ...